Results 101 to 110 of about 393,880 (203)
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008
Item does not contain fulltextTo estimate the mumps vaccine effectiveness (VE) during a large genotype D mumps outbreak, we conducted a cross-sectional study in eight primary schools and associated households in the Netherlands.
Schipper, M. +11 more
core +1 more source
Development of Improved Mumps Vaccine Candidates by Mutating Viral mRNA Cap Methyltransferase Sites in the Large Polymerase Protein. [PDF]
Hao X +7 more
europepmc +1 more source
Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996
Vaccination against mumps in Portugal began in 1987, with the introduction of the combined measles, mumps, and rubella vaccine (MMR) in the national vaccination programme (Programa Nacional de Vacinação: PNV) for both sexes at 15 months. In November 1990,
G Gonçalves +2 more
core +1 more source
Background: Measles, mumps, and rubella (MMR) vaccines have significantly improved public health worldwide. However, variation in vaccine response among immunized individuals poses a threat to both individual protection and herd immunity.
Jesper Kiehn Sørensen +10 more
doaj +1 more source
Understanding MMR vaccine safety [PDF]
Last updated February 2013CDC recommends two doses of the measles, mumps, and rubella vaccine (MMR) for children because it protects them against dangerous, even deadly, diseases.CS233434Nvacsafe-mmr-color-office ...
core
Background: Measles cases increased significantly in the Americas in 2025; the region lost its measles-free status due to the return of endemic transmission in Canada, Mexico, and the U.S., primarily driven by low vaccination rates among unvaccinated or ...
Diana Vilar-Compte +7 more
doaj +1 more source
MMR vaccine (measles, mumps, rubella) : what you need to know
MMR vaccine can prevent measles, mumps, and rubella.mmr.pdf1. Why get vaccinated? -- 2. MMR vaccine -- 3. Talk with your health care provider -- 4. Risks of a vaccine reaction-- 5. What if there is a serious problem? \u2013 6. The National Vaccine Injury
core
A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj
Parotitis Cases Due to Measles-Mumps-Rubella Vaccine
We report ten cases with parotitis following the measles-mumpsrubella (MMR) vaccine which contains Edmonston-Zagreb measles strain, Leningrad-Zagreb mumps strain and Wistar RA 27/3 rubella strain (Tresivac (R), Serum Institute of India, India).
Levent Gorenek +11 more
core +1 more source
MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]
MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]MMR VIS \u2013 Dari (8/6/21)dari_mmr ...
core

